Table 3.
Comparison of the scales used in the research before and after.
| Before CDT |
After CDT |
p** | Z* | |
|---|---|---|---|---|
| Extremity volume, Mean ± S.D. (range) — ml | 680.5 (442.25-884) | 287 (187-385.25) | <0.001 | -7.772 |
| Lymphedema stage Median. (range) | 2 (2-3) | 1 (1-1) | <0.001 | -7.534 |
| EQ-5D-5L,Mean± S.D. (range) | 9 (7.25-10.75) | 5 (5-6) | <0.001 | -7.512 |
| EFS, Mean± S.D. (range) | 9 (4-13) | 6.5 (3-9.75) | <0.001 | -5.452 |
| Quick DASH, Mean± S.D. (range) | 56.81 (34.65- 72.72) | 15.90 (6.81-22.72) | <0.001 | -7.773 |
| HSA, Mean± S.D. (range) | 50 (40-57.5) | 90 (80-90) | <0.001 | 7.850 |
Z*, Wilcoxon Signed Ranks Test; CDT, Complex Decongestive Therapy; ml, Milliliters; DASH, Disabilities of Arm, Shoulder and Hand; EFS, The Edmonton Frailty Scale; EQ-5D-5L, EQ-5D General Quality of Life Scale; HSA, Health status assessment. **p<0,05.